Background: Follicular dendritic cell sarcoma (FDCS) is an extremely rare malignant tumor caused by proliferation of antigen-presenting follicular dendritic cells. The tumor most commonly arises in lymph nodes, with fewer than 30% of cases originating in extranodal sites. Case Presentation: We report the case of a 39-year-old previously healthy male patient who presented with paraneoplastic pemphigus in the setting of a large intraperitoneal mass with no associated lymphadenopathy. The biopsy results showed a cellular proliferation of mildly to moderately atypical oval-to-spindle-shaped cells admixed with a variably dense lymphoplasmacytic infiltrate suggestive of FDCS versus inflammatory myofibroblastic tumor. A pathology review following total resection of the abdominal mass confirmed the diagnosis of FDCS. The tumor cells showed positivity for CD35, CD21, CD45, and CD68, negative ALK staining, and limited smooth muscle actin immunoreactivity. The surgery was complicated by severe Case Rep Oncol 2018;11:353-359 
Introduction
Follicular dendritic cell sarcoma (FDCS) is an extremely rare malignant tumor caused by proliferation of antigen-presenting follicular dendritic cells [1] . It was first described in 1986 by Monda et al. [2] , and has since been reported in approximately 343 patients worldwide [3] . The tumor most commonly arises in lymph nodes, especially in the cervical, mediastinal, or axillary areas, and presents as slow-growing painless lymphadenopathy. Fewer than 30% of cases originate in extranodal sites [1] . The disease's exact etiology and pathogenesis have not yet been elucidated. We herein report a case of paraneoplastic pemphigus (PNP) as the first manifestation of an intraperitoneal FDCS with progressive clinical deterioration following surgery.
Case Presentation
This is the case of a 39-year-old previously healthy male patient with a 20-pack-year smoking history who presented to another institution for a few days' history of oral ulcers that did not respond to oral antifungal (fluconazole) or antiviral (valacyclovir hydrochloride) treatment. He initially denied having any fever, chills, night sweats, decreased appetite, or weight loss. Ten days following presentation, he developed diffuse pemphigoid lesions on the chest, abdomen, and arms ( Fig. 1) . Blood tests at the time revealed isolated neutropenia. A follow-up CT scan of the chest, abdomen, and pelvis showed a large 18 × 8.9 cm necrotic irregular mesenteric mass with no associated retroperitoneal or femoral-inguinal lymphadenopathy. A needle core biopsy of the mass was not conclusive (Fig. 2) .
The patient presented to our institution with febrile neutropenia (WBC count: 900/mm 3 ) and decreased oral intake due to diffuse oral ulcers along with diffuse cutaneous pemphigoid lesions. Viral serology for hepatitis B, hepatitis C, and HIV along with EBV PCR was negative. Bone marrow aspirate and biopsy showed 80% marrow cellularity with markedly left-shifted myelopoiesis, mild dysmegakaryopoiesis, and mild reactive plasmacytosis. There was no evidence of an epithelial or mesenchymal tumor, lymphoproliferative disorder, or acute leukemia. Repeated abdominal biopsy and review of the previous pathology demonstrated a cellular proliferation of mildly to moderately atypical oval-to-spindle-shaped cells admixed with a variably dense lymphoplasmacytic infiltrate. The architecture was fascicular to vaguely storiform, and the stroma was mildly myxoid to collagenous. Tumor cells stained positive for vimentin, CD21, and CD68, and weakly for CD45. They were focally positive for S100 protein, CD34, and SMA (smooth muscle actin), and negative for ALK, CD117, DOG-1, CD3, CD20, CD23, and EBER. Mitotic figures were rare (Fig. 3) .
The clinical, morphologic, and immunohistochemical features of this tumor raised differential diagnostic considerations of FDCS versus inflammatory myofibroblastic tumor, favoring the former based on positivity for CD21, CD45, and CD68, negative ALK staining, and limited SMA immunoreactivity.
The patient was started on high-dose steroids (methylprednisolone 1 mg/kg intravenously once per day), which contributed to improvement of his oral and skin lesions. He also received granulocyte colony-stimulating factor injections while planning for surgical resection.
An external expert pathology review following total resection of the abdominal mass confirmed the diagnosis of FDCS. The immunohistochemical panel performed by the consultant pathologist showed a profile similar to the one obtained at our pathology laboratory, in addition to diffuse positivity for CD35, which confirmed the diagnosis.
The surgery was complicated by severe pneumonia and acidosis, resulting in a prolonged ICU stay and death. Discussion FDCS is a rare malignant tumor arising from dendritic cells localized within lymphoid follicles. It most commonly affects young-to-middle-aged adults (mean age 43 years) with equal predilection for men and women [1] . A review of the literature suggests that FDCS preferentially affects certain ethnicities in specific geographic locations, particularly East Asia, where many of the cases have been reported [4] [5] [6] [7] [8] . No major risk factors were identified to be involved in the occurrence of FDCS.
As expected, this tumor most commonly arises in lymph nodes, with fewer than one-third of cases arising in extranodal sites. Extranodal disease mostly occurs in lymph-rich areas of the head and neck (tonsils and nasopharynx) and, less commonly, intra-abdominal organs [1] . Approximately 12% of FDCS are associated with EBV, especially when occurring in the liver [8] . Our case is among the few reported cases of intraperitoneal FDCS, in the setting of negative EBV PCR.
Our patient presented with PNP, a life-threatening bullous autoimmune disease that is characterized by severe stomatitis and polymorphous skin eruptions [9] [10] . The bone marrow biopsy in our case did not reveal any evidence of a hematological malignancy. To date approximately 14 cases of PNP associated with soft tissue sarcoma have been reported, only 4 of which were FDCS [5] . Lee et al. [5] described a case of PNP with lesions exclusively limited to mucosal membranes without skin involvement that developed shortly following the resection of an FDCS. Chow et al. [4] reported a case of FDCS of the anterior mediastinum presenting initially as PNP in a 62-year-old man.
The histologic appearance and specific immunohistochemical staining pattern is considered the gold standard for the diagnosis of FDCS. Histology characteristically demonstrates a proliferation of spindle-to-ovoid-shaped cells arranged in sheets, fascicles, or whorls in a storiform pattern with interspersed lymphocytes and a low mitotic rate [1, 8] . Typically, the neoplastic cells of FDCS stain positively for CD21, CD35, and CD23, with variable expression of vimentin, CD68, and S100 protein [1, 11] . The immunophenotypic profile in our case was similar to that previously reported in other studies.
Poor prognostic factors for FDCS include extensive necrosis, a large tumor size (>6 cm), cytologic atypia, an intra-abdominal location, and a high proliferative index (mitotic count >5 mitoses/10 high-power fields), all of which increase the likelihood of recurrence, metastasis, and death. An intra-abdominal location was the single most important unfavorable prognostic factor [8, 12] . Our patient had several of these features, which may explain the tumor's aggressive clinical course.
Conclusion
It is essential to maintain a high index of suspicion for FDCS and include it in the differential diagnosis of a spindle cell neoplasm with admixed chronic inflammatory cells, especially in the setting of PNP. The clinical course, although variable, can potentially be grave with associated significant morbidity and mortality. . A large lobulated enhancing soft tissue mesenteric mass with necrotic areas in the left upper quadrant of the abdomen crossing the midline can be seen. The mass is compressing the adjacent organs (colon, spleen, and left kidney), displacing the aorta to the right and compressing the mesenteric vessels. 
